drugset / Trial / NCT04926428

In Situ Thrombolysis With tPA and Inflow Perfusion Analysis in Patient With Severe Covid-19 Infection

NCT04926428

NaSingle-groupOpen-labelDiagnostic

Summary

To estimate the pulmonary response microvascular thrombosis in critical patients due to SARS-Cov-2., at the Hospital General de México "Dr. Eduardo Liceaga", a 15 patients compassionate treatment study was authorized and approved by the ethics and research committee DI-222-2020. Because of the severity of the illness the legal representative sign informed consent in all the patients for performing in-situ thrombolysis with alteplase selectively by catheter in each main pulmonary artery, under fluoroscopic guidance and acquiring images with the iFlow software to assess immediate and post-procedure response.

Timeline

Start
2020-12-25
Primary completion
2021-03-30
Completion
2021-03-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Alteplase Protein / enzyme biologic Other

Indications